Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 8:31 AM ET

Date/Time Source News Release
06/27/2024 01:30 PM EDT ACCESSWIRE Time Sensitive - Reminder from Levi & Korsinsky, LLP to File Claim for Share of Adamas Pharmaceuticals, Inc. (ADMS) Settlement Fund Before Deadline
06/25/2024 01:30 PM EDT ACCESSWIRE $4,650,000 Recovery from Adamas Pharmaceuticals, Inc. (ADMS). L&K, LLP Reminds Shareholders to File a Claim Before Deadline
06/20/2024 01:25 PM EDT ACCESSWIRE Deadline Approaching for Receiving Share of Adamas Pharmaceuticals, Inc. (ADMS) Recovery - Contact Levi & Korsinsky, LLP for Further Details
06/18/2024 01:30 PM EDT ACCESSWIRE Deadline Approaching for Receiving Share of Adamas Pharmaceuticals, Inc. (ADMS) Recovery - Contact Levi & Korsinsky, LLP for Further Details
06/11/2024 12:25 PM EDT ACCESSWIRE Levi & Korsinsky, LLP Announces $4,650,000 Recovery for Adamas Pharmaceuticals, Inc. (ADMS). File Your Claim Before Deadline
06/06/2024 12:15 PM EDT ACCESSWIRE Looming Deadline - Levi & Korsinsky Encourages Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) to File a Share in Class Action Recovery
06/04/2024 12:15 PM EDT ACCESSWIRE Looming Deadline - Levi & Korsinsky Encourages Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) to File a Share in Class Action Recovery
05/30/2024 12:30 PM EDT ACCESSWIRE Levi & Korsinsky, LLP Notifies Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) an Upcoming Claims Deadline in a Class Action Settlement
05/28/2024 12:30 PM EDT ACCESSWIRE Levi & Korsinsky, LLP Notifies Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) an Upcoming Claims Deadline in a Class Action Settlement
05/16/2024 12:30 PM EDT ACCESSWIRE Levi & Korsinsky, LLP Notifies Shareholders of Adamas Pharmaceuticals, Inc. (ADMS) an Upcoming Claims Deadline in a Class Action Settlement
Page

Additional News

As of June 4, 2025 • 8:31 AM ET

Date/Time Source News Release
11/03/2021 06:01 PM EDT SeekingAlpha Supernus up 10% following 2021 earnings guidance boost, Q3 beat
11/01/2021 09:00 AM EDT ACCESSWIRE IA SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, DSPG, HRC, CXP; Shareholders are Encouraged to Contact the Firm
10/28/2021 03:06 PM EDT Zacks Will Adamas Pharmaceuticals (ADMS) Report Negative Q3 Earnings? What You Should Know
10/26/2021 06:40 PM EDT SeekingAlpha Adamas Pharmaceuticals: An Acceptable Buyout At The Perfect Time
10/21/2021 08:05 PM EDT ACCESSWIRE IA SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UMPQ, XLRN, ADMS, AZPN; Shareholders are Encouraged to Contact the Firm
10/21/2021 07:03 AM EDT Motley Fool Why Supernus' Acquisition of Adamas Is a Smart Move
10/18/2021 02:47 PM EDT SeekingAlpha Merger Arbitrage Mondays: Emerson Combines Industrial Software Businesses With Aspen Technology
10/16/2021 07:47 AM EDT SeekingAlpha Wall Street Breakfast: What Moved Markets
10/11/2021 06:37 PM EDT FinancialBuzz.com "The Buzz" Show: Adamas Pharmaceuticals (NASDAQ: ADMS) to be Acquired by Supernus Pharma
10/11/2021 01:44 PM EDT Invezz Supernus Pharmaceuticals to acquire this Pharmaceuticals company for $400 million
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.